subcutaneous glucose sensing dexcom seven plus sensors (Dexcom Inc)
Structured Review
![Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8466/pmc06548466/pmc06548466__nihms-1522480-f0008.jpg)
Subcutaneous Glucose Sensing Dexcom Seven Plus Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/subcutaneous glucose sensing dexcom seven plus sensors/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance"
Article Title: A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance
Journal: Journal of process control
doi: 10.1016/j.jprocont.2019.01.002
Figure Legend Snippet: Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with subcutaneous sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
Techniques Used: Comparison
